ALS Research
ALS Research
For many years, the ALS League has been a reliable source of information about new findings in ALS research. Many patients follow ALS research closely because they are closely involved themselves and want to know what new treatments are being developed. The ALS League helps them by posting the latest information about scientific studies and new treatments on its website. This allows patients to find all the information they need in one place. Good communication about new treatments is not always easy, as promising study results do not always mean that an effective treatment or new drug is available.
Research
-
19-03-2026 Results supported by key neuroaxonal injury biomarkers pNfH and NfL after six months of…
-
30-03-2026 Dear ALS community, We are delighted to share that a new global, pivotal Phase…
-
24 March 2026 CTx1000 designed to clear pathological TDP-43 protein, a central driver of ALS…
-
23 March 2026 Test that distinguishes the debilitating condition from other diseases could spare many…
-
17 March 2026 Acurastem to study SYF2-based therapy in collaboration with academic labs Acurastem has received…
-
21 January 2026 Editor’s ChoiceJournal of the Neurological Sciences | Clinical safety of ultra-high-dose methylcobalamin…
-
26-02-2026 The first participant has been dosed in Regimen I of the HEALEY ALS Platform…
-
6 April 2026 We are delighted to share that recruitment was completed for the Phase…
-
13 March 2026 An international team led by scientists from VIB and the University of…
-
23 February 2026 Phase 3 trial of experimental oral treatment recently cleared by FDA. Early…
-
17-03-2026 NeuroSense kündigt an, dass Ergebnisse der klinischen Probe von PARADIGM Phase 2b von PrimeC…